CN Stock MarketDetailed Quotes

688016 Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd.

Watchlist
  • 111.73
  • -2.69-2.35%
Trading Jan 20 13:01 CST
13.77BMarket Cap20.95P/E (TTM)

Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.13%969.56M
26.63%787.17M
25.38%358.08M
32.43%1.19B
33.75%888.46M
35.49%621.62M
10.75%285.59M
30.95%896.5M
30.20%664.25M
26.64%458.8M
Operating revenue
9.13%969.56M
26.63%787.17M
25.38%358.08M
32.43%1.19B
33.75%888.46M
35.49%621.62M
10.75%285.59M
30.95%896.5M
30.20%664.25M
26.64%458.8M
Total operating cost
-2.22%443.29M
4.21%323.46M
0.43%145.77M
26.37%641.27M
35.02%453.37M
43.80%310.39M
18.43%145.14M
44.42%507.45M
41.72%335.79M
43.09%215.85M
Operating cost
15.56%237.58M
29.55%184.42M
21.34%84.09M
25.65%279.58M
26.88%205.59M
29.25%142.36M
21.15%69.3M
48.06%222.51M
52.40%162.03M
49.04%110.14M
Operating tax surcharges
-3.98%8.73M
32.48%8.24M
31.20%3.66M
45.01%12.03M
41.46%9.09M
24.66%6.22M
-8.91%2.79M
55.85%8.3M
115.74%6.43M
132.40%4.99M
Operating expense
3.58%92.31M
-1.35%62.39M
6.02%26.58M
25.14%130.16M
47.81%89.12M
83.08%63.24M
24.59%25.07M
37.45%104M
16.63%60.29M
15.65%34.54M
Administration expense
17.11%45.47M
4.21%28.32M
-4.52%12.59M
19.58%55.03M
31.05%38.83M
42.15%27.18M
27.13%13.19M
57.42%46.02M
64.67%29.63M
73.25%19.12M
Financial expense
-71.58%-12.05M
-72.22%-8.58M
-204.62%-4.36M
22.94%-8.41M
34.80%-7.02M
10.53%-4.98M
42.79%-1.43M
4.30%-10.92M
-18.49%-10.77M
14.78%-5.57M
-Interest expense (Financial expense)
-19.72%1.16M
-12.15%832.6K
-9.34%443.13K
-12.72%1.82M
-9.04%1.44M
-12.16%947.7K
-11.76%488.76K
17.80%2.09M
32.84%1.58M
86.31%1.08M
-Interest Income (Financial expense)
-86.50%-13.55M
-85.03%-9.27M
-85.72%-4.63M
17.70%-9.26M
31.03%-7.26M
16.17%-5.01M
22.23%-2.5M
18.32%-11.25M
-22.94%-10.53M
18.49%-5.97M
Research and development
-39.50%71.25M
-36.28%48.67M
-35.97%23.19M
25.70%172.88M
33.56%117.77M
45.14%76.39M
5.62%36.22M
34.49%137.54M
31.53%88.18M
30.15%52.63M
Credit Impairment Loss
-4.78%-3.21M
-460.68%-10.03M
-5,406.78%-2.33M
49.19%-1.34M
-522.84%-3.06M
-826.87%-1.79M
113.09%43.9K
-105.39%-2.63M
18.33%-491.86K
175.56%245.99K
Asset Impairment Loss
-1.88%-3.77M
51.84%-2.1M
-132.53%-1.74M
-184.74%-6.35M
-244.51%-3.7M
-554.40%-4.36M
-28.38%-748.78K
14.97%-2.23M
19.98%-1.08M
32.60%-666.82K
Other net revenue
Invest income
1,260.20%79.58M
283.07%16.46M
229.30%7.13M
122.97%9.15M
114.77%5.85M
37.91%4.3M
-32.27%2.16M
-72.67%4.1M
-62.19%2.72M
-38.18%3.12M
-Including: Investment income associates
-1,417.39%-56.39M
84.68%-307.72K
206.61%1.12M
59.47%-3.77M
54.19%-3.72M
54.92%-2.01M
---1.05M
---9.3M
---8.11M
---4.46M
Other revenue
104.31%38.92M
-73.76%4.69M
-8.63%2.4M
-1.73%26.46M
-2.67%19.05M
268.58%17.88M
-31.16%2.62M
46.32%26.92M
41.98%19.57M
849.63%4.85M
Operating profit
40.72%637.79M
44.46%472.74M
50.67%217.77M
38.21%573.85M
29.79%453.22M
30.64%327.25M
2.21%144.53M
14.45%415.21M
19.48%349.19M
16.16%250.5M
Add:Non operating Income
-74.44%61.58K
-70.14%61.48K
-87.01%54.36K
-3.40%334.56K
580.23%240.88K
481.45%205.9K
14,278.24%418.43K
-34.35%346.32K
-93.00%35.41K
-89.72%35.41K
Less:Non operating expense
-2.43%1.62M
1.54%1.65M
5,954.74%1.06M
15.43%1.92M
160.96%1.66M
683.91%1.62M
-90.90%17.52K
1.33%1.66M
-57.09%637.2K
325.11%206.96K
Total profit
40.82%636.23M
44.60%471.16M
49.56%216.76M
38.26%572.27M
29.61%451.8M
30.17%325.84M
2.63%144.93M
14.44%413.9M
19.67%348.59M
15.92%250.33M
Less:Income tax cost
33.02%89.05M
47.68%71.57M
58.56%33.89M
37.52%85.05M
31.99%66.95M
30.39%48.47M
11.65%21.38M
28.45%61.84M
19.47%50.72M
18.96%37.17M
Net profit
42.18%547.18M
44.06%399.58M
48.01%182.87M
38.39%487.22M
29.20%384.85M
30.13%277.37M
1.21%123.55M
12.29%352.05M
19.71%297.87M
15.40%213.15M
Net profit from continuing operation
42.18%547.18M
44.06%399.58M
48.01%182.87M
38.39%487.22M
29.20%384.85M
30.13%277.37M
1.21%123.55M
12.29%352.05M
19.71%297.87M
15.40%213.15M
Less:Minority Profit
-72.39%-6.16M
-82.97%-3.94M
-11.08%-1.43M
-8.02%-5.21M
-18.65%-3.57M
-14.47%-2.15M
8.73%-1.29M
-105.99%-4.83M
-161.27%-3.01M
---1.88M
Net profit of parent company owners
42.46%553.34M
44.36%403.52M
47.62%184.3M
37.98%492.43M
29.10%388.43M
29.99%279.53M
1.10%124.84M
12.99%356.88M
20.36%300.88M
16.42%215.04M
Earning per share
Basic earning per share
24.03%4.49
25.29%3.27
28.90%2.23
37.30%6.81
-13.40%3.62
-12.71%2.61
0.58%1.73
12.98%4.96
20.46%4.18
16.34%2.99
Diluted earning per share
24.03%4.49
25.29%3.27
28.90%2.23
37.30%6.81
-13.40%3.62
-12.71%2.61
0.58%1.73
12.98%4.96
20.46%4.18
16.34%2.99
Other composite income
-1,747.49%-7.15M
138.95%57.36K
-905.05%-35.1K
-119.92%-396.77K
-387.06K
-147.26K
4.36K
1.99M
0
0
Other composite income of parent company owners
-1,747.49%-7.15M
138.95%57.36K
-905.05%-35.1K
-119.92%-396.77K
---387.06K
---147.26K
--4.36K
--1.99M
--0
--0
Total composite income
40.46%540.03M
44.16%399.64M
47.97%182.83M
37.50%486.82M
29.07%384.47M
30.06%277.22M
1.21%123.56M
12.93%354.04M
19.71%297.87M
15.40%213.15M
Total composite income of parent company owners
40.76%546.19M
44.46%403.58M
47.59%184.26M
37.11%492.04M
28.97%388.04M
29.92%279.38M
1.10%124.85M
13.62%358.87M
20.36%300.88M
16.42%215.04M
Total composite income of minority owners
-72.39%-6.16M
-82.97%-3.94M
-11.08%-1.43M
-8.02%-5.21M
-18.65%-3.57M
-14.47%-2.15M
8.73%-1.29M
-105.99%-4.83M
-161.27%-3.01M
---1.88M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.13%969.56M26.63%787.17M25.38%358.08M32.43%1.19B33.75%888.46M35.49%621.62M10.75%285.59M30.95%896.5M30.20%664.25M26.64%458.8M
Operating revenue 9.13%969.56M26.63%787.17M25.38%358.08M32.43%1.19B33.75%888.46M35.49%621.62M10.75%285.59M30.95%896.5M30.20%664.25M26.64%458.8M
Total operating cost -2.22%443.29M4.21%323.46M0.43%145.77M26.37%641.27M35.02%453.37M43.80%310.39M18.43%145.14M44.42%507.45M41.72%335.79M43.09%215.85M
Operating cost 15.56%237.58M29.55%184.42M21.34%84.09M25.65%279.58M26.88%205.59M29.25%142.36M21.15%69.3M48.06%222.51M52.40%162.03M49.04%110.14M
Operating tax surcharges -3.98%8.73M32.48%8.24M31.20%3.66M45.01%12.03M41.46%9.09M24.66%6.22M-8.91%2.79M55.85%8.3M115.74%6.43M132.40%4.99M
Operating expense 3.58%92.31M-1.35%62.39M6.02%26.58M25.14%130.16M47.81%89.12M83.08%63.24M24.59%25.07M37.45%104M16.63%60.29M15.65%34.54M
Administration expense 17.11%45.47M4.21%28.32M-4.52%12.59M19.58%55.03M31.05%38.83M42.15%27.18M27.13%13.19M57.42%46.02M64.67%29.63M73.25%19.12M
Financial expense -71.58%-12.05M-72.22%-8.58M-204.62%-4.36M22.94%-8.41M34.80%-7.02M10.53%-4.98M42.79%-1.43M4.30%-10.92M-18.49%-10.77M14.78%-5.57M
-Interest expense (Financial expense) -19.72%1.16M-12.15%832.6K-9.34%443.13K-12.72%1.82M-9.04%1.44M-12.16%947.7K-11.76%488.76K17.80%2.09M32.84%1.58M86.31%1.08M
-Interest Income (Financial expense) -86.50%-13.55M-85.03%-9.27M-85.72%-4.63M17.70%-9.26M31.03%-7.26M16.17%-5.01M22.23%-2.5M18.32%-11.25M-22.94%-10.53M18.49%-5.97M
Research and development -39.50%71.25M-36.28%48.67M-35.97%23.19M25.70%172.88M33.56%117.77M45.14%76.39M5.62%36.22M34.49%137.54M31.53%88.18M30.15%52.63M
Credit Impairment Loss -4.78%-3.21M-460.68%-10.03M-5,406.78%-2.33M49.19%-1.34M-522.84%-3.06M-826.87%-1.79M113.09%43.9K-105.39%-2.63M18.33%-491.86K175.56%245.99K
Asset Impairment Loss -1.88%-3.77M51.84%-2.1M-132.53%-1.74M-184.74%-6.35M-244.51%-3.7M-554.40%-4.36M-28.38%-748.78K14.97%-2.23M19.98%-1.08M32.60%-666.82K
Other net revenue
Invest income 1,260.20%79.58M283.07%16.46M229.30%7.13M122.97%9.15M114.77%5.85M37.91%4.3M-32.27%2.16M-72.67%4.1M-62.19%2.72M-38.18%3.12M
-Including: Investment income associates -1,417.39%-56.39M84.68%-307.72K206.61%1.12M59.47%-3.77M54.19%-3.72M54.92%-2.01M---1.05M---9.3M---8.11M---4.46M
Other revenue 104.31%38.92M-73.76%4.69M-8.63%2.4M-1.73%26.46M-2.67%19.05M268.58%17.88M-31.16%2.62M46.32%26.92M41.98%19.57M849.63%4.85M
Operating profit 40.72%637.79M44.46%472.74M50.67%217.77M38.21%573.85M29.79%453.22M30.64%327.25M2.21%144.53M14.45%415.21M19.48%349.19M16.16%250.5M
Add:Non operating Income -74.44%61.58K-70.14%61.48K-87.01%54.36K-3.40%334.56K580.23%240.88K481.45%205.9K14,278.24%418.43K-34.35%346.32K-93.00%35.41K-89.72%35.41K
Less:Non operating expense -2.43%1.62M1.54%1.65M5,954.74%1.06M15.43%1.92M160.96%1.66M683.91%1.62M-90.90%17.52K1.33%1.66M-57.09%637.2K325.11%206.96K
Total profit 40.82%636.23M44.60%471.16M49.56%216.76M38.26%572.27M29.61%451.8M30.17%325.84M2.63%144.93M14.44%413.9M19.67%348.59M15.92%250.33M
Less:Income tax cost 33.02%89.05M47.68%71.57M58.56%33.89M37.52%85.05M31.99%66.95M30.39%48.47M11.65%21.38M28.45%61.84M19.47%50.72M18.96%37.17M
Net profit 42.18%547.18M44.06%399.58M48.01%182.87M38.39%487.22M29.20%384.85M30.13%277.37M1.21%123.55M12.29%352.05M19.71%297.87M15.40%213.15M
Net profit from continuing operation 42.18%547.18M44.06%399.58M48.01%182.87M38.39%487.22M29.20%384.85M30.13%277.37M1.21%123.55M12.29%352.05M19.71%297.87M15.40%213.15M
Less:Minority Profit -72.39%-6.16M-82.97%-3.94M-11.08%-1.43M-8.02%-5.21M-18.65%-3.57M-14.47%-2.15M8.73%-1.29M-105.99%-4.83M-161.27%-3.01M---1.88M
Net profit of parent company owners 42.46%553.34M44.36%403.52M47.62%184.3M37.98%492.43M29.10%388.43M29.99%279.53M1.10%124.84M12.99%356.88M20.36%300.88M16.42%215.04M
Earning per share
Basic earning per share 24.03%4.4925.29%3.2728.90%2.2337.30%6.81-13.40%3.62-12.71%2.610.58%1.7312.98%4.9620.46%4.1816.34%2.99
Diluted earning per share 24.03%4.4925.29%3.2728.90%2.2337.30%6.81-13.40%3.62-12.71%2.610.58%1.7312.98%4.9620.46%4.1816.34%2.99
Other composite income -1,747.49%-7.15M138.95%57.36K-905.05%-35.1K-119.92%-396.77K-387.06K-147.26K4.36K1.99M00
Other composite income of parent company owners -1,747.49%-7.15M138.95%57.36K-905.05%-35.1K-119.92%-396.77K---387.06K---147.26K--4.36K--1.99M--0--0
Total composite income 40.46%540.03M44.16%399.64M47.97%182.83M37.50%486.82M29.07%384.47M30.06%277.22M1.21%123.56M12.93%354.04M19.71%297.87M15.40%213.15M
Total composite income of parent company owners 40.76%546.19M44.46%403.58M47.59%184.26M37.11%492.04M28.97%388.04M29.92%279.38M1.10%124.85M13.62%358.87M20.36%300.88M16.42%215.04M
Total composite income of minority owners -72.39%-6.16M-82.97%-3.94M-11.08%-1.43M-8.02%-5.21M-18.65%-3.57M-14.47%-2.15M8.73%-1.29M-105.99%-4.83M-161.27%-3.01M---1.88M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------KPMG Huazhen Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Medical Device Concept
Medical Device Concept
Intraday+0.91%